Regenxbio RGNX
NASDAQ RGNX
$8.47 +0.78 (+10.14%)
At close: Nov 11, 2026 · 4:00 PM EST

Regenxbio (RGNX) Return on Capital Employed [ROCE] (2015 - 2026)

Updated

Regenxbio (RGNX) posted Return on Capital Employed [ROCE] of -58.28% for Q2 2026, down 18.76 percentage points from -39.52% a year earlier but up 20.37 percentage points from the prior quarter.

Analysis

Regenxbio (RGNX) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends

For FY2025, Regenxbio's Return on Capital Employed [ROCE] came in at -47.21%, up 8.77 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of -24.36 percentage points (FY2020 to FY2025).
  • In prior years, Regenxbio's Return on Capital Employed [ROCE] was -55.99% in FY2024 (-9.22 pp), -46.77% in FY2023 (-15.59 pp), -31.18% in FY2022 (-51.67 pp) and 20.50% in FY2021 (+43.36 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -78.65% in Q1 2026 to a high of 19.35% in Q4 2021 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in four of the last eight quarters, with an average year-over-year change of -0.85 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q3 2022, with a gain of 42.77 percentage points; the weakest was Q3 2023, with a drop of 63.01 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -78.65% (Q1 2026), -43.45% (Q4 2025) and -36.15% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Regenxbio 508.48 Mn -228.57 Mn - -41.06%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -41.06%
Jun 30, 2026 -58.28%
Mar 31, 2026 -78.65%
Dec 31, 2025 -43.45%
Sep 30, 2025 -36.15%
Jun 30, 2025 -39.52%
Mar 31, 2025 -42.33%
Dec 31, 2024 -59.93%
Sep 30, 2024 -55.69%
Jun 30, 2024 -49.65%
Mar 31, 2024 -54.10%
Dec 31, 2023 -56.61%
Sep 30, 2023 -49.36%
Jun 30, 2023 -44.89%
Mar 31, 2023 -37.97%
Dec 31, 2022 -36.10%
Sep 30, 2022 13.65%
Jun 30, 2022 13.97%
Mar 31, 2022 13.95%
Dec 31, 2021 19.35%
API Access

Regenxbio Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RGNX&period=max&api_key=YOUR_API_KEY